Merck & Co., Inc.

MRK · CIK 0000310158

19 fiscal years · 69 SEC filings · every number carries its receipt

Compare MRK vs PFE →

Revenue (FY)

$65.01B1.3%

FY2025

Net income (FY)

$18.25B6.6%

FY2025

Free cash flow (FY)

$12.36B31.7%

FY2025

Diluted EPS (FY)

$7.288.0%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.7× since FY2007 · net margin 13.5% → 28.1%

MarginsNet marginFCF margin

FY2025: net 28.1% · free cash flow 19.0% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $16.47B operating cash − $4.11B capex = $12.36B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 42% (FY2008) → 35% (FY2025) · on assets 13.3%

The receipts

Merck & Co., Inc.

MRK · CIK 0000310158

19 fiscal years · 69 SEC filings · every number carries its receipt

Compare MRK vs PFE →

Revenue (FY)

$65.01B1.3%

FY2025

Net income (FY)

$18.25B6.6%

FY2025

Free cash flow (FY)

$12.36B31.7%

FY2025

Diluted EPS (FY)

$7.288.0%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 2.7× since FY2007 · net margin 13.5% → 28.1%

MarginsNet marginFCF margin

FY2025: net 28.1% · free cash flow 19.0% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $16.47B operating cash − $4.11B capex = $12.36B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 42% (FY2008) → 35% (FY2025) · on assets 13.3%

The receipts